Julie Andreina Beltran

Ms. Julie Andreina Beltran


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2026 in Viruses
Verified
Journal Article
Open access
PDF file
JBJulie Andreina Beltran
Julie Andreina Beltran
YGYoneira Fabiola Sulbaran Garcia
Yoneira Fabiola Sulbaran Garcia
Nahir Martinez-UrbinaNahir Martinez-Urbina
Nahir Martinez-Urbina
MCMario Comegna
Mario Comegna
MLMaría Graciela López
María Graciela López
RJRossana C Jaspe
Rossana C Jaspe
Coinfection between hepatitis viruses and human immunodeficiency virus (HIV) significantly increases liver disease and AIDS progression. This retrospective cross-sectional study evaluated the prevalence and genetic diversity of hepatitis B (HBV) and C viruses (HCV) among people living with HIV (PLWH) in Venezuela’s Capital District. A total of 420 serum samples collected between 2022 and 2025 were tested for serological and molecular markers, including whole-genome HBV sequencing via next-generation sequencing (NGS) to characterize viral genotype distribution and mutations. Seroprevalences for HBsAg, anti-HBc, and anti-HCV were 2.9%, 20%, and 4.0%, respectively. HBV exposure was significantly higher in older men, with no differences between treatment-naïve and treated patients. Occult HBV infection (OBI) prevalence decreased compared to 2014 data (seropositive: 7% vs. 16%, seronegative: 0.9% vs. 20%). This decline, along with the higher HBV exposure among older adults, may be partially attributed to the universal HBV vaccination introduced in Venezuela in 1998, as well as modifications in antiretroviral therapy affecting HBV replication. Notably, key vaccine- and diagnostic-escape mutations were detected in OBI cases, highlighting clinical and public health concerns. Increased HCV prevalence appears to be linked to rising intravenous drug use in the country. HBV phylogenetic analysis revealed genotype F3 as predominant, followed by F1b (Cosmopolitan clade), while HCV showed genotype 1a to be the most frequent, followed by 1b and 3a. These findings underscore the success of immunization efforts but highlight the urgent need for continuous molecular surveillance and updated public health policies, including targeted harm-reduction programs, to control viral hepatitis in vulnerable populations.

14 August 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
MSMaría Zulay Sulbarán
María Zulay Sulbarán
JBJulie Andreina Beltran
Julie Andreina Beltran
APANGELICA TIBAIRE MARIN PINEDA
ANGELICA TIBAIRE MARIN PINEDA
ILIría Lozano
Iría Lozano
EMEdgardo Mengual-Moreno
Edgardo Mengual-Moreno
Flor H  PujolFlor H Pujol
Flor H Pujol
Hepatitis D virus (HDV) is a satellite virus that requires the presence of a helper virus, the hepatitis B virus (HBV). Soon after its discovery by Mario Rizzetto in 1977, severe outbreaks of fulminant hepatitis D occurred in the past century, in indigenous populations from the Western and Southern (Amazon) regions of Venezuela, while the indigenous population from the Eastern region (Orinoco Delta) has been found to be free of this virus. Data on the prevalence of HDV infection in Venezuela are still highly imprecise. The aim of this study is to provide insights into the current situation of this disease in the country. Evidence of exposure and infection with HDV was found again mainly in indigenous populations, although also one patient with hepatitis B from the capital was found to be infected with HDV genotype 1. The genotype found in the indigenous Bari population was HDV genotype 1, the same lineage (a putative new subgenotype 1j) previously identified in this region in both Venezuela and Colombia. Although scarce information is still available about the burden of HDV infection in Venezuela, the few studies available are consistent in showing an epidemic concentrated mainly in some, but not all, indigenous populations. Reflex testing is needed to have a better appraisal of this disease in the country.

6 May 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
JBJulie Andreina Beltran
Julie Andreina Beltran
YGYoneira Fabiola Sulbaran Garcia
Yoneira Fabiola Sulbaran Garcia
LSLily Soto
Lily Soto
CPCarlos Pérez
Carlos Pérez
MCMario Comegna
Mario Comegna
RJRossana C Jaspe
Rossana C Jaspe
Hepatitis E virus (HEV) is an emerging zoonotic pathogen of increasing concern in developed regions and represents a major cause of acute viral hepatitis worldwide, primarily transmitted via the fecal–oral route. Although most infections are self-limiting, immunocompromised individuals, such as people living with human immunodeficiency virus (PLWH) and pregnant women, are at risk of severe outcomes, including chronic infection and fatal liver failure, respectively. This study was aimed at evaluating the prevalence and genetic diversity of HEV in PLWH and relevant ecological niches (swine and wastewater) in Venezuela. A total of 417 serum samples from PLWH, 85 wastewater samples, and 67 swine fecal samples were tested for serological or molecular HEV markers. The seroprevalence of anti-HEV antibodies among PLWH was 0.2% for IgM and 5.5% for IgG. HEV RNA was not detected in samples from PLWH or wastewater; however, a 1.5% prevalence of active infection was identified in swine. Phylogenetic analysis of a complete HEV genome revealed an unassignable subtype within genotype 3, tentatively designated as 3p. To the best of our knowledge, this study provides the first molecular characterization and report on HEV frequency in PLWH, wastewater, and swine in Venezuela.